AVTX Similar Chart Price Prediction
The price of AVTX is predicted to go up 66.67%, based on the high correlation periods with THM. The similarity of these two price pattern on the periods is 98.39%.
AVTX
THM
Up: 66.67%Similarity: 98.39%
AVTX Revenue Forecast
AVTX EPS Forecast
AVTX Analyst's Forecast
Julian Harrison
BTIG
Strong Buy
Price Target
$40
Upside
+330.11%
BTIG analyst Julian Harrison initiated coverage of Avalo Therapeutics with a Buy rating and $40 price target. The firm sees the company's AVTX-009 as having best-in-class features that could support preferred positioning in several large indications. Avalo's lead efforts are in hidradenitis suppurativa, where BTIG continues to expect significant reward for more active treatment options, even after key IL-17A/F inhibitors are expected to be well-established, the analyst tells investors in a research note.